Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CFR - Code of Federal Regulations Title 21
  • Print
  • Share
  • E-mail
-

The information on this page is current as of Dec 22, 2023.

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

New Search
Help | More About 21CFR
TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER E - ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS
 
PART 524OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
 

§ 524.86 - Amitraz.

§ 524.154 - Bacitracin, neomycin, and polymyxin B ophthalmic ointment.

§ 524.155 - Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.

§ 524.230 - Buprenorphine.

§ 524.390 - Chloramphenicol ophthalmic ointment.

§ 524.402 - Chlorhexidine.

§ 524.450 - Clotrimazole.

§ 524.463 - Copper naphthenate.

§ 524.575 - Cyclosporine ophthalmic ointment.

§ 524.590 - Diclofenac.

§ 524.660 - Dimethyl sulfoxide.

§ 524.770 - Doramectin.

§ 524.775 - Emodepside and praziquantel.

§ 524.802 - Enrofloxacin and silver sulfadiazine otic emulsion.

§ 524.814 - Eprinomectin.

§ 524.815 - Eprinomectin and praziquantel.

§ 524.838 - Esafoxolaner, eprinomectin, and praziquantel.

§ 524.900 - Famphur.

§ 524.920 - Fenthion.

§ 524.955 - Florfenicol, terbinafine, and betamethasone acetate otic gel.

§ 524.957 - Florfenicol, terbinafine, and mometasone otic solution.

§ 524.960 - Flumethasone, neomycin, and polymyxin B ophthalmic solution.

§ 524.970 - Flunixin.

 Fluocinolone Topical and Otic Dosage Forms
   § 524.981 - [Reserved]
   § 524.981a - Fluocinolone cream.
   § 524.981b - Fluocinolone solution.
   § 524.981c - Fluocinolone and neomycin cream.
   § 524.981d - Fluocinolone and dimethyl sulfoxide solution.
   § 524.981e - Fluocinolone and dimethyl sulfoxide otic solution.
   § 524.998 - Fluralaner.
   § 524.1001 - Fluralaner and moxidectin.
   § 524.1005 - Furazolidone powder.
   § 524.1044 - Gentamicin ophthalmic and topical dosage forms.
   § 524.1044a - Gentamicin ophthalmic solution.
   § 524.1044b - Gentamicin and betamethasone otic solution.
   § 524.1044c - Gentamicin ophthalmic ointment.
   § 524.1044d - Gentamicin and betamethasone ointment.
   § 524.1044e - Gentamicin spray.
   § 524.1044f - Gentamicin and betamethasone spray.
   § 524.1044g - Gentamicin, betamethasone, and clotrimazole ointment.
   § 524.1044h - Gentamicin, mometasone, and clotrimazole otic suspension.
   § 524.1044i - Gentamicin and betamethasone ophthalmic solution.
   § 524.1132 - Hydrocortisone, miconazole, and gentamicin otic suspension.
   § 524.1140 - Imidacloprid and ivermectin.
   § 524.1146 - Imidacloprid and moxidectin.
   § 524.1193 - Ivermectin topical solution.
   § 524.1195 - Ivermectin otic suspension.
   § 524.1200 - Kanamycin ophthalmic and topical dosage forms.
   § 524.1200a - Kanamycin ophthalmic ointment.
   § 524.1200b - Kanamycin ophthalmic solution.
   § 524.1204 - Kanamycin, amphomycin, and hydrocortisone ointment.
   § 524.1240 - Levamisole.
   § 524.1376 - 2-Mercaptobenzothiazole solution.
   § 524.1443 - Miconazole.
   § 524.1445 - Miconazole, polymixin B, and prednisolone suspension.
   § 524.1446 - Milbemycin otic solution.
   § 524.1448 - Mirtazapine transdermal ointment.
   § 524.1450 - Moxidectin.
   § 524.1465 - Mupirocin.
   § 524.1484 - Neomycin ophthalmic and topical dosage forms.
   § 524.1484b - Neomycin, isoflupredone, and tetracaine powder.
   § 524.1484c - Neomycin, isoflupredone, and tetracaine ointment.
   § 524.1484d - Neomycin, hydrocortisone, and tetracaine otic ointment.
   § 524.1484e - Neomycin and polymyxin B ophthalmic solution.
   § 524.1484f - Neomycin, prednisolone, and tetracaine otic suspension.
   § 524.1484g - Neomycin, thiabendazole, and dexamethasone solution.
   § 524.1484h - Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
   § 524.1484i - Neomycin and hydrocortisone ointment.
   § 524.1484k - Neomycin and prednisolone suspension.
   § 524.1580 - Nitrofurazone topical dosage forms.
   § 524.1580a - Nitrofurazone ointment.
   § 524.1580b - Nitrofurazone soluble powder.
   § 524.1580c - Nitrofurazone and butacaine ointment.
   § 524.1600 - Nystatin ophthalmic and topical dosage forms.
   § 524.1600a - Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
   § 524.1600b - Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
   § 524.1610 - Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
   § 524.1662 - Oxytetracycline ophthalmic and topical dosage forms.
   § 524.1662a - Oxytetracycline and hydrocortisone spray.
   § 524.1662b - Oxytetracycline and polymyxin B ophthalmic ointment.
   § 524.1742 - Phosmet emulsifiable liquid.
   § 524.1982 - Proparacaine ophthalmic solution.
   § 524.2080 - Ropinirole.
   § 524.2098 - Selamectin.
   § 524.2099 - Selamectin and sarolaner.
   § 524.2101 - Selenium disulfide suspension.
   § 524.2350 - Tolnaftate cream.
   § 524.2482 - Triamcinolone spray.
   § 524.2620 - Liquid crystalline trypsin, Peru balsam, castor oil.

Authority: 21 U.S.C. 360b.
Source: 40 FR 13873, Mar. 27, 1975, unless otherwise noted.

-
-